Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Prat, M.
	Articles by Comoglio, P. M.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Prat, M.
	Articles by Comoglio, P. M.

Amicone, L., Spagnoli, F., Sp\212t, G., Giordano, S., Tommasini, C., Bernardini, S., De Luca, V., Della Rocca, C., Weiss, M., Comoglio, P. and Tripodi, M (1997). Transgenic expression in the liver of truncated met blocks apoptosis and permits immortalization of hepatocytes. EMBO J 16, 495-503.[Medline]

Bardelli, A., Maina, F., Gout, I., Fry, M. J., Waterfield, M. D., Comoglio, P. M. and Ponzetto, C (1992). Autophosphorylation promotes complex formation of recombinant hepatocyte growth factor receptor with cytoplasmic effectors containing SH2 domains. Oncogene 7, 1973-1978.[Medline]

Bardelli, A., Longati, P., Albero, D., Goruppi, G., Schneider, C., Ponzetto, C. and Comoglio, P (1996). HGF receptor associates with the anti-apoptotic protein bag-1 and prevents cell death. EMBO J 15, 6205-6212.[Medline]

Bellot, F., Moolenaar, W., Kris, R., Mirakhur, B., Verlaan, I., Ullrich, A., Schlessinger, J. and Felder, S (1990). High affinity epidermal growth factor binding is specifically reduced by a monoclonal antibody, and appears necessary for early responses. J. Cell Biol 110, 491-502.[Abstract/Free Full Text]

Bladt, F., Riethmacher, D., Isenmann, S., Aguzzi, A. and Birchmeier, C (1995). Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud [see comments]. Nature 376, 768-771.[Medline]

Blasi, F (1993). Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. BioEssays 15, 105-111.[Medline]

Boccaccio, C., Gaudino, G., Gambarotta, G., Galimi, F. and Comoglio, P. M (1994). Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF. J. Biol. Chem 269, 12846-12851.[Abstract/Free Full Text]

Bussolino, F., Wang, J. M., Defilippi, P., Turrini, F., Sanavio, F., Edgell, C. J., Aglietta, M., Arese, P. and Mantovani, A (1989). Granulocyte-and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 337, 471-473.[Medline]

Bussolino, F., Di Renzo, M. F., Ziche, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnone, L., Coffer, A. and Comoglio, P. M (1992). Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol 119, 629-641.[Abstract/Free Full Text]

Chomczynski, P. and Sacchi, N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem 162, 156-159.[Medline]

Crepaldi, T., D'Alfonso, S. and Richiardi, P (1991). Activated human T cells express2-microglobulin-associated HLA-A,B,C molecules not recognized by W6/32 mAb. Tissue Antigen 37, 138-140.[Medline]

Derman, M. P., Cunha, M. J., Barros, E. J., Nigam, S. K. and Cantley, L. G (1995). HGF-mediated chemotaxis and tubulogenesis require activation of the phosphatidylinositol 3-kinase. Am. J. Physiol 268, 1211-1217.

Ebens, A., Brose, K., Leonardo, E. D., Hanson, M. G., Bladt, F., Birchmeier, C., Barres, B. A. and Tessier-Lavigne, M (1996). Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron 17, 1157-1172.[Medline]

Fuh, G., Cunningham, B. C., Fukunaga, R., Nagata, S., Goeddel, D. V. and Wells, J. A (1992). Rational design of potent antagonists to the human growth hormone receptor. Science 256, 1677-1680.[Abstract/Free Full Text]

Giordano, S., Ponzetto, C., Di Renzo, M. F., Cooper, C. S. and Comoglio, P. M (1989). Tyrosine kinase receptor indistinguishable from the c-met protein. Nature 339, 155-156.[Medline]

Giordano, S., Di Renzo, M. F., Narsimhan, R. P., Cooper, C. S., Rosa, C. and Comoglio, P. M (1989). Biosynthesis of the protein encoded by the c-met proto-oncogene. Oncogene 4, 1383-1388.[Medline]

Giordano, S., Zhen, Z., Medico, E., Gaudino, G., Galimi, F. and Comoglio, P. M (1993). Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene. Proc. Nat. Acad. Sci. USA 90, 649-653.[Abstract/Free Full Text]

Grant, D. S., Kleinman, H. K., Goldberg, I. D., Bhargava, M. M., Nickoloff, B. J., Kinsella, J. L., Polverini, P. and Rosen, E. M (1993). Scatter factor induces blood vessel formation in vivo. Proc. Nat. Acad. Sci. USA 90, 1937-1941.[Abstract/Free Full Text]

Graziani, A., Gramaglia, D., Cantley, L. C. and Comoglio, P. M (1991). The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase. J. Biol. Chem 266, 22087-22090.[Abstract/Free Full Text]

Graziani, A., Gramaglia, D., dalla Zonca, P. and Comoglio, P. M (1993). Hepatocyte growth factor/scatter factor stimulates the Ras-guanine nucleotide exchanger. J. Biol. Chem 268, 9165-9168.[Abstract/Free Full Text]

Hartmann, G., Naldini, L., Weidner, K. M., Sachs, M., Vigna, E., Comoglio, P. M. and Birchmeier, W (1992). A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis. Proc. Nat. Acad. Sci. USA 89, 11574-11578.[Abstract/Free Full Text]

Hartmann, G., Weidner, K. M., Schwarz, H. and Birchmeier, W (1994). The motility signal of scatter factor/hepatocyte growth factor mediatedthrough the receptor tyrosine kinase met requires intracellular action of Ras. J. Biol. Chem 269, 21936-21939.[Abstract/Free Full Text]

Harwerth, I. M., Wels, W., Schlegel, J., Muller, M. and Hynes, N. E (1993). Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth. Br. J. Cancer 68, 1140-1145.[Medline]

Hurwitz, D. R., Emanuel, S. L., Nathan, M. H., Sarver, N., Ullrich, A., Felder, S., Lax, I. and Schlessinger, J (1991). EGF induces increased ligand binding affinity and dimerization of soluble epidermal growth factor (EGF) receptor extracellular domain. J. Biol. Chem 266, 22035-22043.[Abstract/Free Full Text]

Jeffers, M. J., Rong, S. and Vande Woude, G. F (1996). Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-Met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol. Cell Biol 16, 1115-1125.[Abstract]

Kelly, J. D., Haldeman, B. A., Grant, F. J., Murray, M. J., Seifert, R. A., Bowen-Pope, D. F., Cooper, J. A. and Kazlauskas, A (1991). Platelet-derived growth factor (PDGF) stimulates PDGF receptor subunit dimerization and intersubunit trans-phosphorylation. J. Biol. Chem 266, 8987-8992.[Abstract/Free Full Text]

Kobayashi, T., Honke, K., Miyazaki, T., Matsumoto, K., Nakamura, T., Ishizuka, I. and Makita, A (1994). Hepatocyte growth factor specifically binds to sulfoglycolipids. J. Biol. Chem 269, 9817-9821.[Abstract/Free Full Text]

Komada, M. and Kitamura, N (1993). The cell dissociation and motility triggered by scatter factor/hepatocyte growth factor are mediated through the cytoplasmic domain of the c-Met receptor. Oncogene 8, 2381-2390.[Medline]

Lokker, N. A., Mark, M. R., Luis, E. A., Bennett, G. L., Robbins, K. A., Baker, J. B. and Godowski, P. J (1992). Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding. EMBO J 11, 2503-2510.[Medline]

Lokker, N. A. and Godowski, P. J (1993). Generation and characterization of a competitive antagonist of human hepatocyte growth factor, HGF/NK1. J. Biol. Chem 268, 17145-17150.[Abstract/Free Full Text]

Longati, P., Bardelli, A., Ponzetto, C., Naldini, L. and Comoglio, P. M (1994). Tyrosines1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor). Oncogene 9, 49-57.[Medline]

Maina, F., Casagranda, F., Audero, E., Simeone, A., Comoglio, P., Klein, R. a. and Ponzetto, C (1996). Uncoupling of grb2 from the met receptor in vivo reveals complex roles in muscle development. Cell 87, 531-542.[Medline]

Miyazawa, K., Shimomura, T., Naka, D. and Kitamura, N (1994). Proteolytic activation of hepatocyte growth factor in response to tissue injury. J. Biol. Chem 269, 8966-8970.[Abstract/Free Full Text]

Mizuno, K., Inoue, H., Hagiya, M., Shimizu, S., Nose, T., Shimohigashi, Y. and Nakamura, T (1994). Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor. J. Biol. Chem 269, 1131-1136.[Abstract/Free Full Text]

Montesano, R., Matsumoto, K., Nakamura, T. and Orci, L (1991). Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67, 901-908.[Medline]

Nagy, K., Grunberger, G. and Levy, J (1990). Insulin antagonistic effects of insulin receptor antibodies on plasma membrane (Ca2++ Mg2+) ATPase activity: a possible etiology of type B insulin resistance. Endocrinology 126, 45-52.[Abstract]

Nakamura, T (1991). Structure and function of hepatocyte growth factor. Prog. Growth Factor Res 3, 67-85.[Medline]

Naldini, L., Weidner, K. M., Vigna, E., Gaudino, G., Bardelli, A., Ponzetto, C., Narsimhan, R. P., Hartmann, G., Zarnegar, R., Michalopoulos, G. K. et al (1991). Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J 10, 2867-2878.[Medline]

Naldini, L., Tamagnone, L., Vigna, E., Sachs, M., Hartmann, G., Birchmeier, W., Daikuhara, Y., Tsubouchi, H., Blasi, F. and Comoglio, P. M (1992). Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 11, 4825-4833.[Medline]

Naldini, L., Vigna, E., Bardelli, A., Follenzi, A., Galimi, F. and Comoglio, P. M (1995). Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction. J. Biol. Chem 270, 603-611.[Abstract/Free Full Text]

Niranjan, B., Buluwela, L., Yant, J., Perusinghe, N., Atherton, A., Phippard, D., Dale, T., Gusterson, B. and Kamalati, T (1995). HGF/SF: a potent cytokine for mammary growth, morphogenesis and development. Development 121, 2897-2908.[Abstract]

Pepper, M. S., Matsumoto, K., Nakamura, T., Orci, L. and Montesano, R (1992). Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells. J. Biol. Chem 267, 20493-20496.[Abstract/Free Full Text]

Ponzetto, C., Giordano, S., Peverali, F., Della Valle, G., Abate, M. L., Vaula, G. and Comoglio, P. M (1991). c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase. Oncogene 6, 553-559.[Medline]

Ponzetto, C., Bardelli, A., Zhen, Z., Maina, F., dalla Zonca, P., Giordano, S., Graziani, A., Panayotou, G. and Comoglio, P. M (1994). A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 77, 261-271.[Medline]

Prat, M., Crepaldi, T., Gandino, L., Giordano, S., Longati, P. and Comoglio, P (1991). C-terminal truncated forms of Met, the hepatocyte growth factor receptor. Mol. Cell Biol 11, 5954-5962.[Abstract/Free Full Text]

Ridley, A. J., Comoglio, P. M. and Hall, A (1995). Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells. Mol. Cell Biol 15, 1110-1122.[Abstract]

Rong, S., Segal, S., Anver, M., Resau, J. H. and Vande Woude, G. F (1994). Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc. Nat. Acad Sci. USA 91, 4731-4735.[Abstract/Free Full Text]

Royal, I. and Park, M (1996). Hepatocyte growth factor-induced scatter of Madine-Darby canine kidney cells requires phosphatidylinositol 3-kinase. J. Biol. Chem 270, 27780-27787.[Abstract/Free Full Text]

Sachs, M., Weidner, K. M., Brinkmann, V., Walther, I., Obermeier, A., Ullrich, A. and Birchmeier, W (1996). Motogenic and morphogenic activity of epithelial receptor tyrosine kinases. J. Cell Biol 133, 1095-1107.[Abstract/Free Full Text]

Santos, O. F., Barros, E. J., Yang, X. M., Matsumoto, K., Nakamura, T., Park, M. and Nigam, S. K (1994). Involvement of hepatocyte growth factor in kidney development. Dev. Biol 163, 525-529.[Medline]

Schmidt, C., Bladt, F., Goedecke, S., Brinkmann, V., Zschiesche, W., Sharpe, M., Gherardi, E. and Birchmeier, C (1995). Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373, 699-702.[Medline]

Schreiber, A. B., Lax, I., Yarden, Y., Eshhar, Z. and Schleessinger, J (1981). Monoclonal antibodies against receptor for epidermal growth factor induce early and delayed effects of epidermal growth factor. Proc. Nat. Acad. Sci. USA 78, 7535-7539.[Abstract/Free Full Text]

Schreurs, J., Sugawara, M., Arai, K., Ohta, Y. and Miyajima, A (1989). A monoclonal antibody with IL-3-like activity blocks IL-3 binding and stimulates tyrosine phosphorylation. J. Immunol 142, 819-825.[Abstract]

Schwall, R., Chang, L., Godowski, P., Kahn, D., Hillan, K., Bauer, K. and Zioncheck, T (1996). Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2. J. Cell Biol 133, 709-718.[Abstract/Free Full Text]

Silvagno, F., Follenzi, A., Arese, M., Prat, M., Giraudo, E., Gaudino, G., G., C., G., Comoglio, P. M. and Bussolino, F (1995). In vivo activation of met tyrosine kinase by heterodimeric hepatocyte growth factor molecule promotes angiogenesis. Arterioscler. Thromb. Vasc. Biol 15, 1857-1865.[Abstract/Free Full Text]

Soriano, J. V., Pepper, M. S., Nakamura, T., Orci, L. and Montesano, R (1995). Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. J. Cell Sci 108, 413-430.[Abstract]

Spaargaren, M., Defize, L. H., de Laat, S. W. and Boonstra, J (1990). Antibody-induced activation of the epidermal growth factor receptor tyrosine kinase requires the presence of detergent. Biochem. Biophys. Res. Commun 171, 882-889.[Medline]

Spaargaren, M., Defize, L. H., Boonstra, J. and de Laat, S. W (1991). Antibody-induced dimerization activates the epidermal growth factor receptor tyrosine kinase. J. Biol. Chem 266, 1733-1739.[Abstract/Free Full Text]

Stancovski, I., Hurwitz, E., Leitner, O., Ullrich, A., Yarden, Y. and Sela, M (1991). Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth. Proc. Nat. Acad. Sci. USA 88, 8691-8695.[Abstract/Free Full Text]

Streit, A., Stern, C. D., Thery, C., Ireland, G. W., Aparicio, S., Sharpe, M. J. and Gherardi, E (1995). A role for HGF/SF in neural induction and its expression in Hensen's node during gastrulation. Development 121, 813-824.[Abstract]

Tamagnone, L. and Comoglio, P. M (1997). Control of invasive growth by hepatocyte growth factor (HGF) and related scatter factors. Cytokine & Growth Factor Rev 8, 129-142.[Medline]

Taylor, R., Soos, M. A., Wells, A., Argyraki, M. and Siddle, K (1987). Insulin-like and insulin-inhibitory effects of monoclonal antibodies for different epitopes on the human insulin receptor. Biochem. J 242, 123-129.[Medline]

Uehara, Y., Minowa, O., Mori, C., Shiota, K., Kuno, J., Noda, T. and Kitamura, N (1995). Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 373, 702-705.[Medline]

Wei, Y., Lukashev, M., Simon, D. I., Bodary, S. C., Rosenberg, S., Doyle, M. V. and Chapman, H. A (1996). Regulation of integrin function by the urokinase receptor. Science 273, 1551-1555.[Abstract]

Weidner, K. M., Sachs, M. and Birchmeier, W (1993). The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J. Cell Biol 121, 145-154.[Abstract/Free Full Text]

Weidner, K., Di Cesare, S., Sachs, M., Brinkmann, V., Behrens, J. and Birchmeier, W (1996). Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature 384, 173-176.[Medline]

Wolf, D. E., McKinnon, C. A., Daou, M. C., Stephens, R. M., Kaplan, D. R. and Ross, A. H (1995). Interaction with TrkA immobilizes gp75 in the high affinity nerve growth factor receptor complex. J. Biol. Chem 270, 2133-2138.[Abstract/Free Full Text]

Yang, Y., Spitzer, E., Meyer, D., Sachs, M., Niemann, C., Hartmann, G., Weidner, K. M., Birchmeier, C. and Birchmeier, W (1995). Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J. Cell Biol 131, 215-226.[Abstract/Free Full Text]

Yarden, Y. and Schlessinger, J (1987). Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry 26, 1443-1451.[Medline]

Yarden, Y (1990). Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively active. Proc. Nat. Acad. Sci. USA 87, 2569-2573.[Abstract/Free Full Text]

Zhen, Z., Giordano, S., Longati, P., Medico, E., Campiglio, M. and Comoglio, P. M (1994). Structural and functional domains critical for constitutive activation of the HGF-receptor (Met). Oncogene 9, 1691-1697.[Medline]

Zhu, H., Naujokas, M. A. and Park, M (1994). Receptor chimeras indicate that the met tyrosine kinase mediates the motility and morphogenic responses of hepatocyte growth/scatter factor. Cell Growth Differ 5, 359-366.[Abstract]

This article has been cited by other articles:

E. Vigna, G. Pacchiana, M. Mazzone, C. Chiriaco, L. Fontani, C. Basilico, S. Pennacchietti, and P. M. Comoglio
"Active" Cancer Immunotherapy by Anti-Met Antibody Gene Transfer
Cancer Res., November 15, 2008; 68(22): 9176 - 9183.
[Abstract] [Full Text] [PDF]

L. Toschi and P. A. Janne
Single-Agent and Combination Therapeutic Strategies to Inhibit Hepatocyte Growth Factor/MET Signaling in Cancer
Clin. Cancer Res., October 1, 2008; 14(19): 5941 - 5946.
[Abstract] [Full Text] [PDF]

P. A. Zucali, M. G. Ruiz, E. Giovannetti, A. Destro, M. Varella-Garcia, K. Floor, G. L. Ceresoli, J. A. Rodriguez, I. Garassino, P. Comoglio, et al.
Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors
Ann. Onc., September 1, 2008; 19(9): 1605 - 1612.
[Abstract] [Full Text] [PDF]

J. J. Lammerts van Bueren, W. K. Bleeker, A. Brannstrom, A. von Euler, M. Jansson, M. Peipp, T. Schneider-Merck, T. Valerius, J. G. J. van de Winkel, and P. W. H. I. Parren
The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility
PNAS, April 22, 2008; 105(16): 6109 - 6114.
[Abstract] [Full Text] [PDF]

T. Martens, N.-O. Schmidt, C. Eckerich, R. Fillbrandt, M. Merchant, R. Schwall, M. Westphal, and K. Lamszus
A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth In vivo.
Clin. Cancer Res., October 15, 2006; 12(20): 6144 - 6152.
[Abstract] [Full Text] [PDF]

A. Petrelli, P. Circosta, L. Granziero, M. Mazzone, A. Pisacane, S. Fenoglio, P. M. Comoglio, and S. Giordano
Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity
PNAS, March 28, 2006; 103(13): 5090 - 5095.
[Abstract] [Full Text] [PDF]

C. Moog-Lutz, J. Degoutin, J. Y. Gouzi, Y. Frobert, N. B.-d. Carvalho, J. Bureau, C. Creminon, and M. Vigny
Activation and Inhibition of Anaplastic Lymphoma Kinase Receptor Tyrosine Kinase by Monoclonal Antibodies and Absence of Agonist Activity of Pleiotrophin
J. Biol. Chem., July 15, 2005; 280(28): 26039 - 26048.
[Abstract] [Full Text] [PDF]

P. Conrotto, D. Valdembri, S. Corso, G. Serini, L. Tamagnone, P. M. Comoglio, F. Bussolino, and S. Giordano
Sema4D induces angiogenesis through Met recruitment by Plexin B1
Blood, June 1, 2005; 105(11): 4321 - 4329.
[Abstract] [Full Text] [PDF]

A. Motegi, J. Fujimoto, M. Kotani, H. Sakuraba, and T. Yamamoto
ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth
J. Cell Sci., July 1, 2004; 117(15): 3319 - 3329.
[Abstract] [Full Text] [PDF]

P. Devarajan
Has HGF met other partners? Met-independent epithelial morphogenesis induced by HGF. Focus on "Hepatocyte growth factor induces MDCK cell morphogenesis without causing loss of tight junction functional integrity"
Am J Physiol Cell Physiol, March 1, 2004; 286(3): C475 - C477.
[Full Text] [PDF]

A. L. Pollack, G. Apodaca, and K. E. Mostov
Hepatocyte growth factor induces MDCK cell morphogenesis without causing loss of tight junction functional integrity
Am J Physiol Cell Physiol, March 1, 2004; 286(3): C482 - C494.
[Abstract] [Full Text]

J. Vadnais, G. Nault, Z. Daher, M. Amraei, Y. Dodier, I. R. Nabi, and J. Noel
Autocrine Activation of the Hepatocyte Growth Factor Receptor/Met Tyrosine Kinase Induces Tumor Cell Motility by Regulating Pseudopodial Protrusion
J. Biol. Chem., December 6, 2002; 277(50): 48342 - 48350.
[Abstract] [Full Text] [PDF]

E. T. Bowden, G. E. Stoica, and A. Wellstein
Anti-apoptotic Signaling of Pleiotrophin through Its Receptor, Anaplastic Lymphoma Kinase
J. Biol. Chem., September 20, 2002; 277(39): 35862 - 35868.
[Abstract] [Full Text] [PDF]

S. Grisendi, B. Chambraud, I. Gout, P. M. Comoglio, and T. Crepaldi
Ligand-regulated Binding of FAP68 to the Hepatocyte Growth Factor Receptor
J. Biol. Chem., November 30, 2001; 276(49): 46632 - 46638.
[Abstract] [Full Text] [PDF]

T. Otsuka, J. Jakubczak, W. Vieira, D. P. Bottaro, D. Breckenridge, W. J. Larochelle, and G. Merlino
Disassociation of Met-Mediated Biological Responses In Vivo: the Natural Hepatocyte Growth Factor/Scatter Factor Splice Variant NK2 Antagonizes Growth but Facilitates Metastasis
Mol. Cell. Biol., March 15, 2000; 20(6): 2055 - 2065.
[Abstract] [Full Text]

S. GIORDANO, A. MAFFE, T. A. WILLIAMS, S. ARTIGIANI, P. GUAL, A. BARDELLI, C. BASILICO, P. MICHIELI, and P. M. COMOGLIO
Different point mutations in the met oncogene elicit distinct biological properties
FASEB J, February 1, 2000; 14(2): 399 - 406.
[Abstract] [Full Text]

A. Catizone, G. Ricci, V. Arista, A. Innocenzi, and M. Galdieri
Hepatocyte Growth Factor and c-MET Are Expressed in Rat Prepuberal Testis
Endocrinology, July 1, 1999; 140(7): 3106 - 3113.
[Abstract] [Full Text]

J. Deakin and M Lyon
Differential regulation of hepatocyte growth factor/scatter factor by cell surface proteoglycans and free glycosaminoglycan chains
J. Cell Sci., January 6, 1999; 112(12): 1999 - 2009.
[Abstract] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Prat, M.

Articles by Comoglio, P. M.

Search for Related Content

PubMed

PubMed Citation

Articles by Prat, M.

Articles by Comoglio, P. M.

				L. Toschi and P. A. Janne Single-Agent and Combination Therapeutic Strategies to Inhibit Hepatocyte Growth Factor/MET Signaling in Cancer Clin. Cancer Res., October 1, 2008; 14(19): 5941 - 5946. [Abstract] [Full Text] [PDF]

				P. A. Zucali, M. G. Ruiz, E. Giovannetti, A. Destro, M. Varella-Garcia, K. Floor, G. L. Ceresoli, J. A. Rodriguez, I. Garassino, P. Comoglio, et al. Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors Ann. Onc., September 1, 2008; 19(9): 1605 - 1612. [Abstract] [Full Text] [PDF]

				J. J. Lammerts van Bueren, W. K. Bleeker, A. Brannstrom, A. von Euler, M. Jansson, M. Peipp, T. Schneider-Merck, T. Valerius, J. G. J. van de Winkel, and P. W. H. I. Parren The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility PNAS, April 22, 2008; 105(16): 6109 - 6114. [Abstract] [Full Text] [PDF]

				T. Martens, N.-O. Schmidt, C. Eckerich, R. Fillbrandt, M. Merchant, R. Schwall, M. Westphal, and K. Lamszus A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth In vivo. Clin. Cancer Res., October 15, 2006; 12(20): 6144 - 6152. [Abstract] [Full Text] [PDF]

				A. Petrelli, P. Circosta, L. Granziero, M. Mazzone, A. Pisacane, S. Fenoglio, P. M. Comoglio, and S. Giordano Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity PNAS, March 28, 2006; 103(13): 5090 - 5095. [Abstract] [Full Text] [PDF]

				C. Moog-Lutz, J. Degoutin, J. Y. Gouzi, Y. Frobert, N. B.-d. Carvalho, J. Bureau, C. Creminon, and M. Vigny Activation and Inhibition of Anaplastic Lymphoma Kinase Receptor Tyrosine Kinase by Monoclonal Antibodies and Absence of Agonist Activity of Pleiotrophin J. Biol. Chem., July 15, 2005; 280(28): 26039 - 26048. [Abstract] [Full Text] [PDF]

				P. Conrotto, D. Valdembri, S. Corso, G. Serini, L. Tamagnone, P. M. Comoglio, F. Bussolino, and S. Giordano Sema4D induces angiogenesis through Met recruitment by Plexin B1 Blood, June 1, 2005; 105(11): 4321 - 4329. [Abstract] [Full Text] [PDF]

				A. Motegi, J. Fujimoto, M. Kotani, H. Sakuraba, and T. Yamamoto ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth J. Cell Sci., July 1, 2004; 117(15): 3319 - 3329. [Abstract] [Full Text] [PDF]

				P. Devarajan Has HGF met other partners? Met-independent epithelial morphogenesis induced by HGF. Focus on "Hepatocyte growth factor induces MDCK cell morphogenesis without causing loss of tight junction functional integrity" Am J Physiol Cell Physiol, March 1, 2004; 286(3): C475 - C477. [Full Text] [PDF]

				A. L. Pollack, G. Apodaca, and K. E. Mostov Hepatocyte growth factor induces MDCK cell morphogenesis without causing loss of tight junction functional integrity Am J Physiol Cell Physiol, March 1, 2004; 286(3): C482 - C494. [Abstract] [Full Text]

				J. Vadnais, G. Nault, Z. Daher, M. Amraei, Y. Dodier, I. R. Nabi, and J. Noel Autocrine Activation of the Hepatocyte Growth Factor Receptor/Met Tyrosine Kinase Induces Tumor Cell Motility by Regulating Pseudopodial Protrusion J. Biol. Chem., December 6, 2002; 277(50): 48342 - 48350. [Abstract] [Full Text] [PDF]

				E. T. Bowden, G. E. Stoica, and A. Wellstein Anti-apoptotic Signaling of Pleiotrophin through Its Receptor, Anaplastic Lymphoma Kinase J. Biol. Chem., September 20, 2002; 277(39): 35862 - 35868. [Abstract] [Full Text] [PDF]

				S. Grisendi, B. Chambraud, I. Gout, P. M. Comoglio, and T. Crepaldi Ligand-regulated Binding of FAP68 to the Hepatocyte Growth Factor Receptor J. Biol. Chem., November 30, 2001; 276(49): 46632 - 46638. [Abstract] [Full Text] [PDF]

				T. Otsuka, J. Jakubczak, W. Vieira, D. P. Bottaro, D. Breckenridge, W. J. Larochelle, and G. Merlino Disassociation of Met-Mediated Biological Responses In Vivo: the Natural Hepatocyte Growth Factor/Scatter Factor Splice Variant NK2 Antagonizes Growth but Facilitates Metastasis Mol. Cell. Biol., March 15, 2000; 20(6): 2055 - 2065. [Abstract] [Full Text]

				S. GIORDANO, A. MAFFE, T. A. WILLIAMS, S. ARTIGIANI, P. GUAL, A. BARDELLI, C. BASILICO, P. MICHIELI, and P. M. COMOGLIO Different point mutations in the met oncogene elicit distinct biological properties FASEB J, February 1, 2000; 14(2): 399 - 406. [Abstract] [Full Text]

				A. Catizone, G. Ricci, V. Arista, A. Innocenzi, and M. Galdieri Hepatocyte Growth Factor and c-MET Are Expressed in Rat Prepuberal Testis Endocrinology, July 1, 1999; 140(7): 3106 - 3113. [Abstract] [Full Text]

				J. Deakin and M Lyon Differential regulation of hepatocyte growth factor/scatter factor by cell surface proteoglycans and free glycosaminoglycan chains J. Cell Sci., January 6, 1999; 112(12): 1999 - 2009. [Abstract] [PDF]